An Eastern Cooperative Oncology Group phase II study of single agent DHAD, VP-16, aclacinomycin, or spirogermanium in metastatic pancreatic cancer (Q72323495)
Jump to navigation
Jump to search
scientific article published on 01 April 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An Eastern Cooperative Oncology Group phase II study of single agent DHAD, VP-16, aclacinomycin, or spirogermanium in metastatic pancreatic cancer |
scientific article published on 01 April 1994 |
Statements
An Eastern Cooperative Oncology Group phase II study of single agent DHAD, VP-16, aclacinomycin, or spirogermanium in metastatic pancreatic cancer (English)
R F Asbury
A Cnaan
L Johnson
J Harris
S D Zaentz